Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021

Reni Benjamin Maintained (ALLO) at Buy with Decreased Target to $27 on, Oct 12th, 2021

Reni Benjamin of JMP Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $53 to $27 on, Oct 12th, 2021.

Reni has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 2 agree with Reni's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Downgraded from Strong Buy to Hold on, Friday, October 8th, 2021
  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Friday, October 8th, 2021


These are the ratings of the 2 analyists that currently disagree with Reni


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $45 on, Friday, October 8th, 2021
  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $36 on, Friday, September 24th, 2021